Pharmacy

More Articles ...

More Articles ...

The FINANCIAL -- Amgen on October 9 announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for Prolia (denosumab) for ...

The FINANCIAL -- Commenting on the Group’s sales, Roche CEO Severin Schwan said: “Based on the strong sales growth of our Pharmaceuticals and Diagnostics Divisions in the first nine months, I am ...

Videos

Watch the video